Tema Oncology ETF (CANC) Holdings $26.80 +0.03 (+0.11%) Closing price 08/27/2025 03:58 PM EasternExtended Trading$26.72 -0.08 (-0.30%) As of 08/27/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Top 25 CANC HoldingsRankCompanyCurrent PriceWeightShares Held1RHHBYRoche$40.88+1.3%4.88%84,4142RVMDRevolution Medicines$38.04+2.0%4.74%85,4813BBIOBridgeBio Pharma$49.59+1.5%4.68%66,6424MRUSMerus$67.28+0.6%4.58%46,4635LLYEli Lilly and Company$734.54-0.2%4.45%4,0446AstraZeneca PLCN/A4.26%19,1417Novartis AGN/A4.12%23,8878GMABGenmab A/S$24.78+1.0%3.81%118,0949SMMTSummit Therapeutics$24.81-8.0%3.80%97,00710NUVLNuvalent$76.13+1.6%3.36%28,819 Get the Latest News and Ratings for CANC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. 11ZLABZai Lab$32.56-5.0%3.29%58,51512ACLXArcellx$69.903.26%30,73713EXELExelixis$38.51+0.4%3.25%60,43214ONCBeOne Medicines$300.14-2.8%3.14%7,00515BMYBristol Myers Squibb$47.60+0.8%3.14%48,80616LEGNLegend Biotech$34.72-1.0%2.99%51,42317AMGNAmgen$287.97-0.6%2.92%6,65418ABBVAbbVie$208.24-0.1%2.71%9,62519IDYAIDEAYA Biosciences$25.00+0.6%2.29%63,21420MRKMerck & Co., Inc.$84.16-1.0%2.13%18,37321IMNMImmunome$9.95-2.1%1.64%104,68522JANXJanux Therapeutics$23.35-1.2%1.62%45,42123Daiichi Sankyo Company, LimitedN/A1.56%42,48524COGTCogent Biosciences$12.37+1.1%1.44%84,77125ARGXargenex$707.960.0%1.40%1,404 Geographic ExposureUnited States83.2%Switzerland4.6%Netherlands4.4%United Kingdom4.4%Japan2.3%Israel1.0%Currency ExposureUSD88.7%CHF4.6%GBP4.4%JPY2.3%Sector ExposureHealth Care97.6%Consumer Discretionary0.9%Information Technology0.4%Industry ExposureBiotechnology89.7%Pharmaceuticals6.0%Diversified Consumer Services2.4%IT Services0.4%Health Care Equipment & Supplies0.4%SubIndustry ExposureBiotechnology77.2%Pharmaceuticals13.9%Internet Services & Infrastructure0.4%Life Sciences Tools & Services0.4% Related Companies and Tools Related Companies SPDR Galaxy Hedged Digital Asset Ecosystem ETF Portfolio Companies AOT Growth & Innovation ETF Portfolio Companies Xtrackers Artificial Intelligence and Big Data ETF Portfolio Companies Global X E-Commerce ETF Portfolio Companies Tradr 1X Short Innovation Daily ETF Portfolio Companies Global X Aging Population ETF Portfolio Companies REX Crypto Equity Premium Income ETF Portfolio Companies Spear Alpha ETF Portfolio Companies Roundhill Daily 2X Long Magnificent Seven ETF Portfolio Companies Sprott Critical Materials ETF Portfolio Companies This page (NASDAQ:CANC) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access